arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Teleflex Incorporated

TFX Health Care Medical/Dental Instruments
$138.36
▼ -0.1% Today
as of Sep 4, 16:55 ET
Last 30 days +3.10% Jul 28 → Sep 04
$131.11 $134.05 $136.99 $139.92 $142.86 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$138.70
High
$140.59
Low
$137.35
Volume
$463,907
Avg Vol
$730,120
Mkt Cap
$6.1B
P/E (TTM)
66.51
Beta
—
52w High
$145.00
52w Low
$100.18
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 10:30 PR Business Wire
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
Sep 4 · 09:37 Insider Monkey
Teleflex (TFX): Guidance Cut Meets A Bigger Buyback Push
Aug 29 · 14:15 Simply Wall St.
Teleflex (TFX) Stock Trades At A Discount On Cash Flow But A Premium On Sales
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$100
$145
85% of range
Avg surprise (last 3)
+9.0%
Avg reaction (last 2)
-0.7%
50% positive
Latest IV / EM
35%
EM ±5.4% · $140 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.21$1.84$2.47$3.10$3.73 Actual $1.62Actual $2.35Actual $2.90Actual $2.91Est $2.88Actual $3.73Est $3.36Actual $1.39Est $1.21Actual $2.28 AprJulOctMar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-8M$144M$295M$447M$599M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.28 — — — — financials
Thu May 7, 2026Mar/2026 $1.39 $1.21 +14.9% -52.2% +6.9% earnings
Thu Jul 31, 2025Jun/2025 $3.73 $3.36 +11.0% — — earnings
Thu May 1, 2025Mar/2025 $2.91 $2.88 +1.0% — -8.2% earnings
Sun Oct 1, 2023Oct 2023 $2.90 — — — — financials
Sun Jul 2, 2023Jul 2023 $2.35 — — — — financials
Sun Apr 2, 2023Apr 2023 $1.62 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$570M$548M——$443M$414M——
Cost of revenue$239M$241M—$461M$177M$159M—$334M
Gross profit$332M$307M——$266M$255M——
Operating income$73M$20M——$91M$76M——
Net income$100M$-8M——$123M$95M——
EPS (diluted)$2.28$-0.18——$2.77$2.07——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$300M$309M$379M$354M$254M$284M$290M$243M
Inventory$352M$381M$404M$802M$694M$644M$600M$640M
Total current assets$1.88B$1.86B$1.94B$1.99B$1.72B$1.54B$1.47B$1.50B
Total assets$6.79B$6.78B$6.95B$7.87B$7.38B$7.16B$7.10B$7.49B
Long-term debt$2.72B$2.51B$2.54B$2.57B$1.80B$1.81B$1.56B$1.66B
Total liabilities$3.88B$3.70B$3.82B$4.05B$3.13B$3.07B$2.82B$3.00B
Total equity$2.90B$3.08B$3.12B$3.82B$4.24B$4.10B$4.28B$4.48B

Implied volatility — last 90 days

32%71%110%148%187% Jun 07 — IV 54% · EM ±7.5%Jun 08 — IV 54% · EM ±7.1%Jun 09 — IV 57% · EM ±7.2%Jun 10 — IV 59% · EM ±6.9%Jun 11 — IV 62% · EM ±6.8%Jun 12 — IV 66% · EM ±6.7%Jun 15 — IV 92% · EM ±6.6%Jun 16 — IV 137% · EM ±8.1%Jun 17 — IV 187% · EM ±7.8%Jun 19 — IV 45% · EM ±9.9%Jun 22 — IV 47% · EM ±9.8%Jun 23 — IV 40% · EM ±8.2%Jun 24 — IV 38% · EM ±7.7%Jun 25 — IV 40% · EM ±7.8%Jun 26 — IV 38% · EM ±7.4%Jun 29 — IV 43% · EM ±7.6%Jun 30 — IV 47% · EM ±8.1%Jul 01 — IV 44% · EM ±7.4%Jul 02 — IV 41% · EM ±6.6%Jul 03 — IV 42% · EM ±6.6%Jul 06 — IV 54% · EM ±7.5%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 52% · EM ±6.5%Jul 09 — IV 46% · EM ±5.5%Jul 10 — IV 48% · EM ±5.3%Jul 13 — IV 54% · EM ±4.5%Jul 14 — IV 71% · EM ±5.1%Jul 15 — IV 97% · EM ±5.7%Jul 16 — IV 65% · EM ±2.7%Jul 20 — IV 45% · EM ±10.5%Jul 21 — IV 45% · EM ±10.5%Jul 22 — IV 45% · EM ±10.4%Jul 23 — IV 48% · EM ±10.9%Jul 24 — IV 50% · EM ±11.0%Jul 27 — IV 49% · EM ±10.3%Jul 28 — IV 49% · EM ±10.1%Jul 29 — IV 49% · EM ±9.9%Jul 30 — IV 54% · EM ±10.5%Jul 31 — IV 59% · EM ±11.2%Aug 03 — IV 63% · EM ±11.1%Aug 04 — IV 61% · EM ±10.6%Aug 05 — IV 64% · EM ±10.6%Aug 06 — IV 56% · EM ±9.0%Aug 07 — IV 51% · EM ±8.0%Aug 10 — IV 65% · EM ±9.0%Aug 11 — IV 62% · EM ±8.2%Aug 12 — IV 71% · EM ±8.8%Aug 13 — IV 50% · EM ±5.9%Aug 14 — IV 46% · EM ±5.1%Aug 17 — IV 63% · EM ±5.3%Aug 18 — IV 61% · EM ±4.4%Aug 19 — IV 71% · EM ±4.2%Aug 20 — IV 51% · EM ±2.1%Aug 24 — IV 36% · EM ±7.5%Aug 25 — IV 37% · EM ±7.5%Aug 26 — IV 35% · EM ±6.9%Aug 27 — IV 35% · EM ±6.9%Aug 28 — IV 34% · EM ±6.6%Aug 31 — IV 33% · EM ±5.8%Sep 01 — IV 35% · EM ±6.0%Sep 02 — IV 36% · EM ±6.1%Sep 03 — IV 35% · EM ±5.7%Sep 04 — IV 35% · EM ±5.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in